Report Content
Chapter 1 Methodology & Scope
1.1 Market scope & definitions
1.2 Research design
1.2.1 Research approach
1.2.2 Data collection methods
1.3 Base estimates & calculations
1.3.1 Base year calculation
1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
1.5.1 Primary sources
1.5.2 Data mining sources
Chapter 2 Executive Summary
2.1 Industry 3600 synopsis
Chapter 3 Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Advancement in cell culture technologies
3.2.1.2 Increase in demand for personalized medicine
3.2.1.3 Rise in prevalence of chronic disease
3.2.1.4. Technological advancement in 3 D spheroid
3.2.2 Industry pitfalls & challenges
3.2.2.1 Lack of robust disease models
3.2.2.2 High cost of development and maintenance
3.3 Growth potential analysis
3.4 Technology landscape
3.5 Regulatory landscape
3.6 Porter’s analysis
3.7 PESTEL analysis
Chapter 4 Competitive Landscape, 2023
4.1 Introduction
4.2 Company market share analysis
4.3 Company matrix analysis
4.4 Competitive analysis of major market players
4.5 Competitive positioning matrix
4.6 Strategic dashboard
Chapter 5 Market Estimates and Forecast, By Type, 2018 – 2032 ($ Mn)
5.1 Key trends
5.2 Organoids
5.2.1 By Type
5.2.1.1 Neural organoids
5.2.1.2 Hepatic organoids
5.2.1.3 Intestinal organoids
5.2.1.4 Other organoid type
5.2.2 By Method
5.2.2.1 General submerged method for organoid culture
5.2.2.2 Crypt organoid culture techniques
5.2.2.3 Air Liquid Interface (ALI) method
5.2.2.4 Other organoid methods
5.2.3 By Source
5.2.3.1 Primary tissue
5.2.3.2 Stem cells
5.3 Spheroids
5.3.1 By Type
5.3.1.1 Multicellular tumor spheroids
5.3.1.2 Neurospheres
5.3.1.3 Mammospheres
5.3.1.4 Hepatospheres
5.3.2 By Method
5.3.2.1 Micropatterned plates
5.3.2.2 Low cell attachment plates
5.3.2.3 Hanging drop method
5.3.2.4 Other spheroid methods
5.3.3 By Source
5.3.3.1 Cell line
5.3.3.2 iPSCs derived cells
Chapter 6 Market Estimates and Forecast, By Application, 2018 – 2032 ($ Mn)
6.1 Key trends
6.2 Developmental biology
6.3 Personalized medicine
6.4 Regenerative medicine
6.5 Disease pathology studies
6.6 Drug toxicity & efficacy testing
Chapter 7 Market Estimates and Forecast, By End-Use, 2018 – 2032 ($ Mn)
7.1 Key trends
7.2 Pharmaceutical & biotechnology companies
7.3 Academic & research institutes
7.4 Hospital & diagnostic centers
Chapter 8 Market Estimates and Forecast, By Region, 2018 – 2032 ($ Mn)
8.1 Key trends
8.2 North America
8.2.1 U.S.
8.2.2 Canada
8.3 Europe
8.3.1 Germany
8.3.2 UK
8.3.3 France
8.3.4 Spain
8.3.5 Italy
8.3.6 Netherlands
8.3.7 Rest of Europe
8.4 Asia Pacific
8.4.1 Japan
8.4.2 China
8.4.3 India
8.4.4 Australia
8.4.5 South Korea
8.4.6 Rest of Asia Pacific
8.5 Latin America
8.5.1 Brazil
8.5.2 Mexico
8.5.3 Rest of Latin America
8.6 Middle East and Africa
8.6.1 South Africa
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Rest of Middle East and Africa
Chapter 9 Company Profiles
9.1 STEMCELL Technologies
9.2 Corning Incorporated
9.3 Merck KGaA
9.4 Greiner Bi-One
9.5 InSphero Inc.
9.6 Promega Corporation
9.7 Thermo Fisher Scientific Inc.
9.8 Lonza Group Ltd.
9.9 Prellis Biologics
9.10 AMSBIO LLC
